These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4277856)

  • 21. [Analysis of the high risk factors of endometrial adenocarcinoma--abnormal excretion in urinary steroids in androgen sterilized rats].
    Morikawa S; Naito M; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jul; 36(7):995-1000. PubMed ID: 6235300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urinary excretion of neutral 17-ketosteroids, androsterone and etiocholanolone in healthy women and women with early and advanced breast cancer].
    Bacigalupo G; Lingk H
    Arch Geschwulstforsch; 1968; 32(1):95-107. PubMed ID: 5678251
    [No Abstract]   [Full Text] [Related]  

  • 23. The metabolism of steroid hormones in breast cancer: a reappraisal.
    Brooks SC
    Curr Top Mol Endocrinol; 1976; 4():36-50. PubMed ID: 800358
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dehydroepiandrosterone, androsterone and etiocholanolone in plasma and following urine administration of dehydroepiandrosterone sulfate].
    Oertel GW; Menzel P
    Arzneimittelforschung; 1970 Mar; 20(3):417-8. PubMed ID: 4245595
    [No Abstract]   [Full Text] [Related]  

  • 25. Urinary excretion of 11-deoxy-17-ketosteroids by patients with breast cancer with or without ovulatory cycles.
    Grattarola R
    J Endocrinol; 1967 May; 38(1):77-8. PubMed ID: 4225834
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of age, obesity, starvation, and changes in adrenocortical and ovarian activity on the urinary excretion of dehydroepiandrosterone relative to androsterone plus etiocholanolone: relevance to the measurement of breast cancer discriminants in women.
    Metcalf MG
    Clin Biochem; 1974 Jun; 7(2):119-30. PubMed ID: 4276446
    [No Abstract]   [Full Text] [Related]  

  • 27. Urinary steroid excretion in patients with advanced breast cancer.
    Fotherby K; Sellwood RA; Burn JI
    Br J Surg; 1970 Nov; 57(11):859. PubMed ID: 5482303
    [No Abstract]   [Full Text] [Related]  

  • 28. Circadian variations of urinary 11-deoxy-17-ketosteroids in normal and hirsute women.
    Toccafondi R; Bianchi G; Rolandi E; Madeddu G
    Riv Crit Clin Med; 1970; 70(1):126-34. PubMed ID: 4268050
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of age, stage of disease, and menstrual status on urinary steroids in women with early breast cancer.
    Hamilton T; Miller WR; Champion HR; Bruce J
    Br J Surg; 1971 Nov; 58(11):861-2. PubMed ID: 5166402
    [No Abstract]   [Full Text] [Related]  

  • 30. [17-ketosteroid fraction excretion in women during the development of menopause with and without climacteric neurosis].
    Korneev GIa
    Probl Endokrinol (Mosk); 1967; 13(3):33-7. PubMed ID: 4241240
    [No Abstract]   [Full Text] [Related]  

  • 31. [Excretion of C-19 and C21 steroids in the urine under normal and pathological conditions of development and maturation].
    Teller WM
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 142(3):222-96. PubMed ID: 4230920
    [No Abstract]   [Full Text] [Related]  

  • 32. A longitudinal study of steroid excretion patterns in children during adolescent growth.
    Gupta D
    Steroidologia; 1970; 1(5):267-94. PubMed ID: 4331676
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of wedge excision of the ovary on steroid excretion in virilism].
    Botella-Llusia J; Guadalix FJ; Bagazgoitia FJ; Ruiz MC
    Zentralbl Gynakol; 1974 Jul; 96(28):884-95. PubMed ID: 4277173
    [No Abstract]   [Full Text] [Related]  

  • 34. [Steroid balance in breast cancers of varying histological structure].
    Samundzhan EM; Gorevaia AN; Kartavova NS; Nekrasov PIa
    Vopr Onkol; 1980; 26(9):37-41. PubMed ID: 6252695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of corticotrophin on urinary 17-ketosteroid excretion in adrenalectomized females.
    Vejlsted H; Kehlet H; Nielsen MD; Blichert-Toft M
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):746-50. PubMed ID: 168711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal status of breast cancer. III. Further analysis of ovarian-adrenal dysfunction.
    Kodama M; Kodama T; Miura S; Yoshida M
    J Natl Cancer Inst; 1977 Jul; 59(1):49-54. PubMed ID: 875062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Difficulty of collecting and preserving urine during gas chromatography determination of steroid hormones].
    Gleispach H
    Z Klin Chem Klin Biochem; 1969 Jul; 7(4):379-83. PubMed ID: 4243111
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of a district therapeutist in early diagnosis of breast cancer].
    Sviatukhina OV; Vishniakova EG; Vikmanis UE
    Ter Arkh; 1975; 47(1):62-8. PubMed ID: 1114450
    [No Abstract]   [Full Text] [Related]  

  • 39. [Urinary 11-deoxy-17-ketosteroids in breast cancer patients considered in relation to the menstrual cycle: ovulatory and non ovulatory].
    Grattarola R
    Tumori; 1967; 53(2):129-39. PubMed ID: 4227798
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship between hormonal cytology and steroid excretion in post-menopausal women.
    de Waard F; Thijssen JH
    J Endocrinol; 1970 Dec; 48(4):xxxvi. PubMed ID: 5489055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.